Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
General Internal Medicine
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
When would you consider upfront eculizumab for sickle cell hyperhemolysis?
How long after eculizumab infusion would you wait before giving blood transfusions?
Related Questions
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
Is there specific data on using luspatercept for sickle beta+ thalassemia with transfusion-dependent anemia?
For von Willebrand type 2B, do you expect a decline in platelet count over time as vWF increases with age?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?